MENU
IMTX
AS OF
Nov 20, 04:59 PM (EDT)
Price
$10.11
Change
-$0.23 (-2.23%)
Capitalization
1.23B
125 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
IMTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Immatics (IMTX) Earnings Date & Reports

Immatics NV is a biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients... Show more

A.I. Advisor
published Earnings

IMTX is expected to report earnings to fall 20.79% to -33 cents per share on March 25

Immatics IMTX Stock Earnings Reports
Q4'25
Est.
$-0.33
Q3'25
Missed
by $0.04
Q2'25
Missed
by $0.28
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.74
The last earnings report on November 17 showed earnings per share of -41 cents, missing the estimate of -38 cents. With 423.80K shares outstanding, the current market capitalization sits at 1.23B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
IMTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. IMTX showed earnings on November 17, 2025. You can read more about the earnings report here.
View AI-Driven Trading for IMTX
A.I. Advisor
published General Information

General Information

a clinical stage biopharmaceutical company, which engages in the research and development of T cell receptor-based immunotherapies for the treatment of cancer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Paul-Ehrlich-Strasse 15
Phone
+49 707153970
Employees
343
Web
https://www.immatics.com